Benicar (olmesartan): Ongoing Safety Review
Audience: Cardiology, Internal Medicine
ISSUE: FDA is evaluating data from two clinical trials in which patients with type 2 diabetes taking the blood pressure medication, Benicar (olmesartan), an angiotensin II receptor blocker, had a higher…
No related posts.




facebook
rss
twitter